MarketInOut Stock Screener Log In | Sign Up

Fractyl Health Inc

NASDAQ • Healthcare • Biotechnology • Quote as of 10/30/2026
Fractyl Health Inc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization11.81 mln
Float11.27 mln
Earnings Date11/18/2026

Piotroski F-Score

2 / 9
Weak

1-Year Forecast

36.80
Transformational upside

Relative Strength

2 / 100
Severely lagging

ROE

-6,790
Deeply negative

ROA

-110
Deeply negative

Business Description

Fractyl Health is a medical company focused on finding lasting solutions for type 2 diabetes and obesity. Its two main programs include a minimally invasive outpatient procedure that targets a root cause of these conditions in the digestive tract, and a gene therapy designed to produce long-term remission by changing how the pancreas regulates key metabolic hormones. Founded in 2010 and based in Burlington, Massachusetts, the company has grown from its origins as Fractyl Laboratories into a broader health-focused organization.

Key Fundamentals

EPS-10.73
ROE-6,790
ROIC-197
ROA-110
EBITDA, mln-105
EV / EBITDA-0.24
EV / EBIT-0.24

Quote Details

Last 0.9765
Change -0.015 (-1.51%)
Open 0.96
Volume 386,581
Turnover 377,496
Average Volume 1,114,583

Financial Strength

Piotroski F-Score 2 / 9
1-Year Target Price36.80
Short Ratio1.44
Short % of Float2.14

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -9.58% 10 / 100   
1 Month -81.92% 0 / 100   
2 Months -89.84% 1 / 100   
6 Months -88.36% 3 / 100   
1 Year -93.49% 4 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog